Transactions
uniQure’s sale to of a portion of its royalty interest in HEMGENIX® to HealthCare Royalty and Sagard Healthcare Partners
Date Announced:
05/15/2023
client:
uniQure N.V.
Status:
Closed – 06/2023
Value:
Up to $400 million
Date Announced:
05/15/2023
client:
uniQure N.V.
Status:
Closed – 06/2023
Value:
Up to $400 million